ThinkEquity Starts Celldex Therapeutics (CLDX) at Buy

June 1, 2012 7:58 AM EDT Send to a Friend
Get Alerts CLDX Hot Sheet
Price: $12.41 +0.89%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 18 | New: 13
Trade CLDX Now!
ThinkEquity initiates coverage on Celldex Therapeutics (NASDAQ: CLDX) with a Buy. PT $7.00.

For an analyst ratings summary and ratings history on Celldex Therapeutics click here. For more ratings news on Celldex Therapeutics click here.

Shares of Celldex Therapeutics closed at $4.17 yesterday, with a 52 week range of $2.05-$5.66.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

New Coverage

Related Entities

ThinkEquity

Add Your Comment